Risk of Share Dilution from Stock Options
First written in FY2020. 5 of 16 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
- FY2026MitigatedAnnual report
「As of the end of February 2026, potential shares were 320,200, approximately 3.11% of shares issued.」
The number of potential shares and their ratio to shares issued decreased from 367,900 shares and approximately 3.57% in the previous fiscal year to 320,200 shares and approximately 3.11%. - FY2025MitigatedAnnual report
「As of the end of February 2025, potential shares were 367,900, approximately 3.57% of shares issued.」
The number of potential shares and their ratio to shares issued decreased from 380,050 shares and 3.69% in the previous fiscal year to 367,900 shares and approximately 3.57%. - FY2025-Q1RestatedAnnual report
「During the cumulative first quarter of the current consolidated fiscal year, there were no material changes in the emergence of new business or other risks, or in the business or other risks described in the securities report for the previous fiscal year.」
It states that there were no material changes in the risk of share dilution from stock options. - FY2024MitigatedAnnual report
「As of the end of the consolidated fiscal year, the number of potential shares under share acquisition rights was 380,050, equivalent to 3.69% of the total 10,308,150 shares issued.」
Potential shares stood at 380,050, or 3.69% of total shares issued, and the scale of dilution decreased from the level including the large fifth and sixth series of share acquisition rights disclosed in the previous fiscal year. - FY2024-Q3RestatedAnnual report
「During the cumulative third quarter of the current consolidated fiscal year, there were no material changes in the emergence of new business or other risks, or in the business or other risks described in the securities report for the previous fiscal year.」
It states that there were no material changes in the risk of share dilution from stock options. - FY2024-Q2RestatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, there were no material changes in the emergence of new business or other risks, or in the business or other risks described in the securities report for the previous fiscal year.」
It states that there were no material changes in the risk of share dilution from stock options. - FY2023-Q3RestatedAnnual report
「During the cumulative third quarter of the current consolidated fiscal year, there were no material changes in the emergence of new business or other risks, or in the business or other risks described in the securities report for the previous fiscal year.」
It states that there were no material changes in the risk of share dilution from stock options. - FY2023-Q2RestatedAnnual report
「Fifth and sixth series of share acquisition rights」
The issuance terms, exercise periods and minimum exercise prices for 1,300,000 shares under the fifth series of share acquisition rights and 700,000 shares under the sixth series were disclosed in detail. The new potential shares remained within the total of 2,000,000 shares indicated in the previous quarter, and no applicable exercise activity was reported for the second-quarter accounting period. - FY2023-Q1WorsenedAnnual report
「Potential shares issued in connection with this issuance Potential shares: 2,000,000 shares (100 shares per share acquisition right)」
The fifth and sixth series of share acquisition rights were issued through a third-party allotment, and 2,000,000 new potential shares were disclosed. - FY2022MaterialisedAnnual report
「Number of such bonds with share acquisition rights subject to exercise-price adjustment exercised during the period (units) 2,290 Number of shares delivered upon exercise during the period (shares) 229,000」
In the fiscal year ended February 2022, 229,000 shares were delivered upon exercise of the fourth series of share acquisition rights, bringing the cumulative number of shares delivered to 371,000. While the fourth series had no remaining balance at the fiscal year-end, 428,400 potential shares, equivalent to 4.17% of total shares issued, remained under the stock options. - FY2022-Q3MaterialisedAnnual report
「1 September 2021–30 November 2021 10,350 10,262,400 (Note) 2. This represents an increase resulting from the exercise of share acquisition rights.」
During the third-quarter accounting period, 10,350 shares were issued upon exercise of the share acquisition rights, with part of the dilution factor materialising as an actual share issuance. - FY2022-Q2MaterialisedAnnual report
「The exercise of the fourth series of stock acquisition rights issued through a third-party allotment on 6 November 2020, consisting of stock acquisition rights with an exercise price adjustment clause and a suspension designation clause, increased capital and capital surplus by ¥327.475 million each.」
The shares were actually issued upon exercise of the share acquisition rights, increasing stated capital and capital surplus. - FY2022-Q1MaterialisedAnnual report
「Number of shares delivered in connection with the bonds with stock acquisition rights, etc., with an exercise price adjustment clause, exercised during the current quarterly accounting period (shares) 229,000」
The exercise of stock acquisition rights resulted in the delivery of 229,000 shares during the current quarter, bringing the cumulative number of shares delivered to 371,000. Part of the dilution factor represented by potential shares has materialized as an actual share issuance. - FY2021WorsenedAnnual report
「As of the end of the fiscal year, the number of potential shares represented by stock acquisition rights was 378,000, equivalent to 11.88% of the 3,182,000 issued shares.」
The number of potential shares and the ratio to issued shares increased from 189,500 shares and 8.33% to 378,000 shares and 11.88%, respectively. - FY2021-Q3WorsenedAnnual report
「The type and total number of shares underlying these stock acquisition rights shall be 371,000 shares of the Company's common stock.」
For the fourth series of stock acquisition rights, the Company disclosed 371,000 potential underlying shares, of which 30,000 were exercised and delivered during the current quarterly accounting period. In addition to the existing stock options, the disclosure shows the scale of a new dilution factor and its exercise results. - FY2020First statedAnnual report
「As of the end of the fiscal year, the number of potential shares represented by stock acquisition rights was 189,500, equivalent to 8.33% of the 2,275,000 issued shares.」
The disclosure describes the dilution of existing shareholders' share value and voting-rights ratios resulting from the exercise of stock acquisition rights granted to officers and employees.